X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (85) 85
index medicus (80) 80
female (55) 55
male (43) 43
surgery (33) 33
adult (32) 32
middle aged (30) 30
analysis (29) 29
animals (27) 27
oncology (26) 26
aged (23) 23
poland (19) 19
mice (16) 16
laparoscopy (15) 15
medicine & public health (15) 15
obesity (14) 14
therapy (14) 14
history (13) 13
immunotherapy (13) 13
medicine (13) 13
medicine, research & experimental (13) 13
immunology (12) 12
bariatric surgery (11) 11
cancer (11) 11
health aspects (11) 11
prognosis (11) 11
proteins (11) 11
retrospective studies (11) 11
treatment outcome (11) 11
breast cancer (10) 10
diagnosis (10) 10
laparoscopic surgery (10) 10
poland - epidemiology (10) 10
research (10) 10
adolescent (9) 9
biochemistry & molecular biology (9) 9
complications (9) 9
experience (9) 9
medicine, general & internal (9) 9
risk factors (9) 9
sleeve gastrectomy (9) 9
care and treatment (8) 8
cell biology (8) 8
cytokines (8) 8
gastric bypass (8) 8
guidelines (8) 8
impact (8) 8
management (8) 8
medical research (8) 8
medicine, experimental (8) 8
mortality (8) 8
surgical outcomes (8) 8
survival (8) 8
time factors (8) 8
biotechnology & applied microbiology (7) 7
breast neoplasms - drug therapy (7) 7
breast neoplasms - pathology (7) 7
cancer vaccines - immunology (7) 7
enhanced recovery (7) 7
gastrointestinal surgery (7) 7
incidence (7) 7
length of stay (7) 7
medical colleges (7) 7
melanoma (7) 7
metaanalysis (7) 7
morbidity (7) 7
multidisciplinary sciences (7) 7
outcomes (7) 7
patients (7) 7
research article (7) 7
surveys and questionnaires (7) 7
vaccination (7) 7
young adult (7) 7
age factors (6) 6
aged, 80 and over (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
breast-cancer (6) 6
cancer vaccines - genetics (6) 6
care (6) 6
cutaneous melanoma (6) 6
infant (6) 6
materials science, multidisciplinary (6) 6
melanoma - therapy (6) 6
perioperative care (6) 6
pharmacology & pharmacy (6) 6
tumor cells, cultured (6) 6
urban population - statistics & numerical data (6) 6
urbanization (6) 6
alloys (5) 5
article (5) 5
attitude to health (5) 5
birds (5) 5
cancer vaccines (5) 5
cancer vaccines - therapeutic use (5) 5
cell line, tumor (5) 5
child (5) 5
children (5) 5
clinical trials as topic (5) 5
dendritic cells (5) 5
diabetes (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (13) 13
UTL at Downsview - May be requested (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Pontifical Inst. Mediaeval Studies - Library use only (2) 2
Pontifical Inst. Mediaeval Studies - Reference (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Trinity College (John W Graham) - Reference (2) 2
UofT at Mississauga - Reference (2) 2
UofT at Mississauga - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Robarts - Petro Jacyk (1) 1
Robarts - Reference (1) 1
Robarts - Woodhouse Collection 13th floor (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Augustine's Seminary - Reference (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
St. Michael's College (John M. Kelly) - Reference (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Thomas Fisher Rare Book - Reference (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Opinion on Investigational Drugs, ISSN 1354-3784, 02/2010, Volume 19, Issue 2, pp. 265 - 274
Importance of the field: Hepatocellular cancer (HCC) is the fifth most common malignancy worldwide and third leading cause of cancer death. HCC is highly... 
mTOR inhibitors | targeted therapy | receptor tyrosine kinase inhibitors | signaling pathways | hepatocellular cancer | angiogenesis | Signaling pathways | Angiogenesis | Receptor tyrosine kinase inhibitors | MTOR inhibitors | Targeted therapy | Hepatocellular cancer | CARCINOMA HCC | INDUCIBLE FACTOR 1-ALPHA | MONOCLONAL-ANTIBODY | VIRUS-X-PROTEIN | CELL-LINES | FACTOR RECEPTOR | PHASE-II TRIAL | PHARMACOLOGY & PHARMACY | HEPATOCYTE GROWTH | ENDOTHELIAL GROWTH-FACTOR | Humans | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Liver Neoplasms - drug therapy | Angiogenesis Inhibitors - pharmacology | Antineoplastic Agents - therapeutic use | Intracellular Signaling Peptides and Proteins - metabolism | Receptor Protein-Tyrosine Kinases - metabolism | Carcinoma, Hepatocellular - drug therapy | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neovascularization, Pathologic - drug therapy | Liver Neoplasms - metabolism | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Angiogenesis Inhibitors - therapeutic use | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Neovascularization, Pathologic - metabolism | TOR Serine-Threonine Kinases | Drug Delivery Systems - methods | Protein-Serine-Threonine Kinases - metabolism | Carcinoma, Hepatocellular - metabolism
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 06/2012, Volume 21, Issue 6, pp. 785 - 795
Introduction: Bone metastases are a frequent complication of cancer, occurring in up to 70% of patients with advanced breast or prostate cancer.... 
Indexing in process
Journal Article
Expert Review of Molecular Diagnostics, ISSN 1473-7159, 05/2010, Volume 10, Issue 4, pp. 509 - 519
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 40, pp. 66239 - 66254
Journal Article
International Journal of Cancer, ISSN 0020-7136, 11/2018, Volume 143, Issue 10, pp. 2425 - 2436
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2009, Volume 13, Issue 2, pp. 74 - 80
Journal Article
Archives of Medical Science, ISSN 1734-1922, 2009, Volume 5, Issue 2, pp. 277 - 280
Pyrimidine analogues such as 5-fluorouracil (5-FU) are widely used in adjuvant and palliative treatment of various solid tumours. However, their administration... 
5-Fluorouracil | Pyrimidine analogues | Cardiotoxicity | 5-fluorouracil | CAPECITABINE | MEDICINE, GENERAL & INTERNAL | cardiotoxicity | CONTINUOUS-INFUSION | FLUOROURACIL | pyrimidine analogues
Journal Article
Wspólczesna Onkologia, ISSN 1428-2526, 11/2010, Volume 14, Issue 6, p. 385
  Primary sarcomas of the heart are extremely rare. They are often diagnosed at advanced stage or even first during autopsy, because the early symptoms are... 
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 02/2013, Volume 22, Issue 2, pp. 181 - 190
Introduction: For many years systemic treatment of advanced/metastatic melanoma has been based on chemotherapy or immunotherapy. However, even very toxic... 
trametinib | immunotherapy | ipilimumab | vemurafenib | melanoma | PD1 | BRAF mutations | dabrafenib | Vemurafenib | Immunotherapy | Ipilimumab | Melanoma | Dabrafenib | Trametinib | INTERLEUKIN-2 | IMPROVED SURVIVAL | OPEN-LABEL | BRAF | MALIGNANT-MELANOMA | SORAFENIB | METASTATIC MELANOMA | MEK INHIBITION | KIT | RESISTANCE | PHARMACOLOGY & PHARMACY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Skin Neoplasms - drug therapy | Humans | Melanoma - enzymology | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | CTLA-4 Antigen - biosynthesis | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Enzyme Inhibitors - administration & dosage | Skin Neoplasms - enzymology | Programmed Cell Death 1 Receptor - biosynthesis | Cytokines - immunology | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Neoplasm Invasiveness | Antibodies, Monoclonal - pharmacology | Enzyme Inhibitors - pharmacology | Treatment Outcome | Clinical Trials as Topic | Melanoma - pathology | CTLA-4 Antigen - immunology | Enzyme Inhibitors - therapeutic use | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Melanoma - immunology | Melanoma - drug therapy | Cytokines - antagonists & inhibitors | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Cytokines - biosynthesis | Index Medicus
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2010, Volume 14, Issue 6, pp. 385 - 388
Journal Article
Wspólczesna Onkologia, ISSN 1428-2526, 03/2009, Volume 13, Issue 2, p. 74
  For many years renal cell cancer (RCC) has been supposed to be resistant to systemic treatment. The growth and progression of RCC, which is known to be an... 
Journal Article
Roczniki Panstwowego Zakladu Higieny, ISSN 0035-7715, 2010, Volume 61, Issue 2, p. 171
Journal Article
Roczniki Państwowego Zakładu Higieny, ISSN 0035-7715, 2010, Volume 61, Issue 2, pp. 171 - 178
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.